Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06350643

Quit and Screen Project

The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.

The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Virginia Commonwealth Univesity

Richmond, Virginia, 23284, United States

Location contact

Mignonne Guy, PhD

CONTACT

[email protected]

804-828-1731

Mignonne Guy, PhD

PRINCIPAL_INVESTIGATOR

About this study

This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.

In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Current National Medical Association (NMA) member
  • Serves a patient clientele who smokes
  • At least 20% of time (1 day per week) devoted to clinical care
  • Currently screens clients for tobacco use in the clinic
  • Have the capacity to refer smokers to a patient navigator
  • Willing to provide informed consent
  • Will provide contact email, address and phone.

Exclusion criteria

  • None

Treatment and study plan

Quit and Screen Project training

Other

This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.

G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

Other

The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.

Primary outcomes

  1. Familiarity with treatment guidelines for tobacco and nicotine treatment

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.

  2. Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    These questions assessed providers perceptions about the benefits of smoking cessation and the benefits of providers advising patients to quit smoking.

  3. Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Perceptions about provider barriers to addressing smoking cessation with patient were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.

  4. Provider Perceptions about patient barriers to smoking cessation

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Perceptions about patient barriers to smoking cessation were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.

  5. Behavioral intentions to screen and advise patients about smoking cessation

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    A set of questions based on the Theory of Planned Behavior assessed provider's intention to screen patients for tobacco use and provide them interventions and referrals for treatment.

  6. Familiarity with lung cancer screening guidelines

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.

  7. Knowledge about low dose computed tomography for lung cancer screening

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Familiarity with treatment guidelines was assessed using an modified question from the questions published by Kota et al. 2022, Carter-Bawa et al. 2022, and the National Cancer Institute National Survey of Primary Care Physicians' Recommendations & Practices for Breast, Cervical, Lung, & Colorectal Cancer Screening.

  8. Perceptions about shared decision-making for low dose computed tomography for lung cancer screening

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Questions were modified from the questions published by Forcino et al. in 2018.

  9. Perceptions about provider barriers to referring patients to low dose computed tomography for lung cancer screening

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Questions were modified from questions published by Coughlin et al. 2020.

  10. Provider Perceptions about patient barriers to get screened for lung cancer

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Perceptions about patient barriers to getting screened for lung cancer were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.

  11. Behavioral intentions to advise patients to get screened for lung cancer via low dose computed tomography

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    A set of questions based on the Theory of Planned Behavior assessed provider's intention to advise patients who smoke to get screened for lung cancer via low dose computed tomography.

Secondary outcomes

  1. Characteristics of enrolled healthcare providers

    Time frame: This is pre-post design. This outcome will be measured during the pre-test immediately before participants complete the 30-60 minute online training.

    Study process tracking metrics will be used to assess the demographic, training, and clinical practice characteristics of providers who enroll in the training.

  2. Retention: Percent of providers complete the training after enrolling

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Study process tracking metrics will be used to assess retention of providers who enroll in the training.

  3. Adherence to completing training modules: Percent of modules completed

    Time frame: This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.

    Study process tracking metrics and training completion data will be used to assess the percent of training modules completed (i.e., the number of modules completed divided by the total available modules).

  4. Preferences regarding training

    Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.

    Questions will assess provider feedback on the online training module.

  5. Satisfaction with training

    Time frame: This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.

    Questions will assess provider satisfaction on the online training module.

Study contacts

Contact information is provided by the study sponsor or research team.

Ashley Clawson, PhD

CONTACT

[email protected]

501-526-6413

Mignonne Guy, PhD

CONTACT

[email protected]

804-828-1731

Sponsors and collaborators

Lead sponsor

University of Arkansas

Other

Collaborators

  • Coalition for a Tobacco Free Arkansas
  • National Institute on Minority Health and Health Disparities (NIMHD)
  • National Medical Association
  • Virginia Commonwealth University

Registry information

Official study title

The Quit and Screen Project

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 5, 2024
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.